Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subject-driven versus investigator-driven titration of BIAsp 30 plus metformin in type 2 diabetes
2010-024303-27Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of biphasic insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Change in HbA1c from baseline to week 20/end of trial. Started May 2011; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-024303-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024303-27.